Health
Causes of Death by Rate
Leading causes of death globally ranked by rate.
deathcauseshealthmortality
283 of 283 rows
Cause↕ | Rate↕ | % total↕ | % change 2007–2017↕ |
|---|---|---|---|
| All causes | 737.7 | 100 | −14.2 |
| I. Communicable, maternal, neonatal and nutritional disorders | 143.8 | 19.49 | −31.8 |
| Respiratory infections and tuberculosis | 50.5 | 6.85 | −24.5 |
| Tuberculosis | 14.9 | 2.02 | −31.4 |
| Drug-susceptible tuberculosis | 13.2 | 1.79 | −31.9 |
| Multidrug-resistant tuberculosis without extensive drug resistance | 1.6 | 0.22 | −28.6 |
| Extensively drug-resistant tuberculosis | 0.2 | 0.03 | −7.7 |
| Lower respiratory infections | 35.4 | 4.8 | −21.1 |
| Upper respiratory infections | 0.1 | 0.01 | −42.1 |
| Otitis media | 0 | 0 | −50.4 |
| Enteric infections | 24.4 | 3.31 | −29.9 |
| Diarrhoeal diseases | 21.6 | 2.93 | −30.2 |
| Typhoid and paratyphoid | 1.9 | 0.26 | −27.8 |
| (Typhoid fever) | 1.6 | 0.22 | −29.1 |
| (Paratyphoid fever) | 0.3 | 0.04 | −18.9 |
| iNTS | 0.8 | 0.11 | −24.8 |
| Other intestinal infectious diseases | 0 | 0 | −44.7 |
| Sexually transmitted infections | 13.9 | 1.88 | −53.6 |
| HIV/AIDS | 12.1 | 1.64 | −56.5 |
| HIV/AIDS – Drug-susceptible Tuberculosis | 2.5 | 0.34 | −61.1 |
| HIV/AIDS – Multidrug-resistant Tuberculosis without extensive drug resistance | 0.3 | 0.04 | −58.1 |
| HIV/AIDS – Extensively drug-resistant tuberculosis | 0 | 0 | −20.3 |
| HIV/AIDS resulting in other diseases | 9.3 | 1.26 | −55.1 |
| Sexually transmitted infections excluding HIV | 1.8 | 0.24 | −14.4 |
| Syphilis | 1.7 | 0.23 | −14.3 |
| Chlamydial infection | 0 | 0 | −15.2 |
| Gonococcal infection | 0 | 0 | −14.9 |
| Other sexually transmitted infections | 0 | 0 | −15.9 |
| Neglected tropical diseases and malaria | 10.1 | 1.37 | −36.1 |
| Malaria | 8.7 | 1.18 | −37.3 |
| Chagas disease | 0.1 | 0.01 | −21.1 |
| Leishmaniasis | 0.1 | 0.01 | −67.8 |
| (Visceral leishmaniasis) | 0.1 | 0.01 | −67.8 |
| African trypanosomiasis (sleeping sickness) | 0 | 0 | −82.8 |
| Schistosomiasis | 0.1 | 0.01 | −28.5 |
| Cysticercosis | 0 | 0 | −27.3 |
| Cystic echinococcosis | 0 | 0 | −41.9 |
| Dengue | 0.5 | 0.07 | 40.7 |
| Yellow fever | 0.1 | 0.01 | −23.3 |
| Rabies | 0.2 | 0.03 | −54.8 |
| Intestinal nematode infections | 0 | 0 | −47.2 |
| (Ascariasis) | 0 | 0 | −47.2 |
| Ebola virus disease | 0 | 0 | −98.4 |
| Zika virus disease | 0 | 0 | – |
| Other neglected tropical diseases | 0.2 | 0.03 | −3.7 |
| Other infectious diseases | 11.6 | 1.57 | −33.8 |
| Meningitis | 4 | 0.54 | −27.8 |
| Pneumococcal meningitis | 0.6 | 0.08 | −22.4 |
| H influenzae type B meningitis | 1.1 | 0.15 | −40.6 |
| Meningococcal infection | 0.4 | 0.05 | −37.1 |
| Other meningitis | 2 | 0.27 | −17.3 |
| Encephalitis | 1.2 | 0.16 | −14.3 |
| Diphtheria | 0.1 | 0.01 | −28.6 |
| Whooping cough (pertussis) | 1.4 | 0.19 | −27.1 |
| Tetanus | 0.5 | 0.07 | −59.6 |
| Measles | 1.4 | 0.19 | −59.3 |
| Varicella (chickenpox) and herpes zoster (shingles) | 0.2 | 0.03 | −29.2 |
| Acute hepatitis | 1.6 | 0.22 | −24.5 |
| Acute hepatitis A | 0.3 | 0.04 | −38.7 |
| Acute hepatitis B | 1.1 | 0.15 | −19.6 |
| Acute hepatitis C | 0 | 0 | −32.1 |
| Acute hepatitis E | 0.2 | 0.03 | −25.8 |
| Other unspecified infectious diseases | 1.1 | 0.15 | −13.4 |
| Maternal and neonatal disorders | 29.5 | 4 | −26.6 |
| Maternal disorders | 2.5 | 0.34 | −30.7 |
| Maternal haemorrhage | 0.5 | 0.07 | −56.4 |
| Maternal sepsis and other pregnancy related infections | 0.3 | 0.04 | −33.5 |
| Maternal hypertensive disorders | 0.4 | 0.05 | −13.0 |
| Maternal obstructed labour and uterine rupture | 0.2 | 0.03 | −25.2 |
| Maternal abortive outcome | 0.2 | 0.03 | −15.7 |
| Ectopic pregnancy | 0.1 | 0.01 | −19.2 |
| Indirect maternal deaths | 0.4 | 0.05 | −12.5 |
| Late maternal deaths | 0 | 0 | −9.5 |
| Maternal deaths aggravated by HIV/AIDS | 0 | 0 | −32.1 |
| Other maternal disorders | 0.3 | 0.04 | −16.5 |
| Neonatal disorders | 27.1 | 3.67 | −26.2 |
| Neonatal preterm birth | 9.9 | 1.34 | −28.1 |
| Neonatal encephalopathy due to birth asphyxia and trauma | 8.1 | 1.1 | −26.5 |
| Neonatal sepsis and other neonatal infections | 3.1 | 0.42 | −14.4 |
| Hemolytic disease and other neonatal jaundice | 0.7 | 0.09 | −39.3 |
| Other neonatal disorders | 5.3 | 0.72 | −25.7 |
| Nutritional deficiencies | 3.8 | 0.52 | −33.6 |
| Protein-energy malnutrition | 3.3 | 0.45 | −34.6 |
| Other nutritional deficiencies | 0.5 | 0.07 | −25.8 |
| II. Non-communicable diseases | 536.1 | 72.67 | −7.9 |
| Cardiovascular diseases | 233.1 | 31.6 | −10.3 |
| Rheumatic heart disease | 3.7 | 0.5 | −21.3 |
| Ischaemic heart disease | 116.9 | 15.85 | −9.7 |
| Stroke | 80.5 | 10.91 | −13.6 |
| Ischaemic stroke | 36.6 | 4.96 | −11.8 |
| Intracerebral hemorrhage | 38.2 | 5.18 | −15.7 |
| Subarachnoid hemorrhage | 5.7 | 0.77 | −9.4 |
| Hypertensive heart disease | 12.3 | 1.67 | 7.5 |
| Non-rheumatic valvular heart disease | 2 | 0.27 | −5.3 |
| Non-rheumatic calcific aortic valve disease | 1.4 | 0.19 | −1.0 |
| Non-rheumatic degenerative mitral valve disease | 0.5 | 0.07 | −14.0 |
| Other non-rheumatic valve diseases | 0.1 | 0.01 | −17.8 |
| Cardiomyopathy and myocarditis | 4.8 | 0.65 | −16.6 |
| Myocarditis | 0.6 | 0.08 | −13.3 |
| Alcoholic cardiomyopathy | 1.1 | 0.15 | −40.5 |
| Other cardiomyopathy | 3.1 | 0.42 | −3.6 |
| Atrial fibrillation and flutter | 4 | 0.54 | 2.6 |
| Aortic aneurysm | 2.2 | 0.3 | −8.5 |
| Peripheral vascular disease | 1 | 0.14 | 10.5 |
| Endocarditis | 1.1 | 0.15 | 1.0 |
| Other cardiovascular and circulatory diseases | 4.7 | 0.64 | −7.9 |
| Neoplasms | 121.2 | 16.43 | −4.4 |
| Lip and oral cavity cancer | 2.4 | 0.33 | 4.0 |
| Nasopharynx cancer | 0.9 | 0.12 | −3.0 |
| Other pharynx cancer | 1.4 | 0.19 | 7.9 |
| Oesophageal cancer | 5.5 | 0.75 | −14.5 |
| Stomach cancer | 11 | 1.49 | −17.1 |
| Colon and rectum cancer | 11.5 | 1.56 | −4.3 |
| Liver cancer | 10.2 | 1.38 | −2.5 |
| (Liver cancer due to hepatitis B) | 4 | 0.54 | −6.2 |
| (Liver cancer due to hepatitis C) | 3 | 0.41 | −2.1 |
| (Liver cancer due to alcohol use) | 1.6 | 0.22 | 0.6 |
| (Liver cancer due to NASH) | 0.8 | 0.11 | 7.6 |
| (Liver cancer due to other causes) | 0.8 | 0.11 | −0.9 |
| Gallbladder and biliary tract cancer | 2.2 | 0.3 | −6.7 |
| Pancreatic cancer | 5.6 | 0.76 | 4.8 |
| Larynx cancer | 1.6 | 0.22 | −7.7 |
| Tracheal, bronchus, and lung cancer | 23.7 | 3.21 | −2.0 |
| Malignant skin melanoma | 0.8 | 0.11 | −5.1 |
| Non-melanoma skin cancer | 0.8 | 0.11 | 2.7 |
| (Non-melanoma skin cancer (squamous-cell carcinoma)) | 0.8 | 0.11 | 2.7 |
| Breast cancer | 7.6 | 1.03 | −2.6 |
| Cervical cancer | 3.2 | 0.43 | −7.2 |
| Uterine cancer | 1.1 | 0.15 | −10.4 |
| Ovarian cancer | 2.2 | 0.3 | −1.0 |
| Prostate cancer | 5.5 | 0.75 | −2.5 |
| Testicular cancer | 0.1 | 0.01 | −9.4 |
| Kidney cancer | 1.8 | 0.24 | −1.3 |
| Bladder cancer | 2.6 | 0.35 | −5.4 |
| Brain and nervous system cancer | 3.1 | 0.42 | 3.8 |
| Thyroid cancer | 0.5 | 0.07 | −1.2 |
| Mesothelioma | 0.4 | 0.05 | −3.4 |
| Hodgkin lymphoma | 0.4 | 0.05 | −16.8 |
| Non-Hodgkin's lymphoma | 3.2 | 0.43 | 0.1 |
| Multiple myeloma | 1.4 | 0.19 | −0.4 |
| Leukaemia | 4.5 | 0.61 | −9.6 |
| Acute lymphoid leukaemia | 0.7 | 0.09 | −1.5 |
| Chronic lymphoid leukaemia | 0.5 | 0.07 | −10.3 |
| Acute myeloid leukaemia | 1.3 | 0.18 | −1.0 |
| Chronic myeloid leukaemia | 0.3 | 0.04 | −19.9 |
| Other leukaemia | 1.8 | 0.24 | −15.6 |
| Other malignant cancers | 4.6 | 0.62 | 0.1 |
| Other neoplasms | 1.3 | 0.18 | 7.4 |
| Myelodysplastic, myeloproliferative and other hematopoietic neoplasms | 1.3 | 0.18 | 7.1 |
| Other benign and in situ neoplasms | 0.1 | 0.01 | 15.5 |
| Chronic respiratory diseases | 51.4 | 6.97 | −14.2 |
| Chronic obstructive pulmonary disease | 42.2 | 5.72 | −13.6 |
| Pneumoconiosis | 0.3 | 0.04 | −16.7 |
| (Silicosis) | 0.1 | 0.01 | −15.5 |
| (Asbestosis) | 0 | 0 | −8.3 |
| (Coal workers pneumoconiosis) | 0 | 0 | −26.6 |
| (Other pneumoconiosis) | 0 | 0 | −17.5 |
| Asthma | 6.3 | 0.85 | −23.9 |
| Interstitial lung disease and pulmonary sarcoidosis | 1.9 | 0.26 | 11.4 |
| Other chronic respiratory diseases | 0.7 | 0.09 | −3.2 |
| Digestive diseases | 30.3 | 4.11 | −10.7 |
| Cirrhosis and other chronic liver diseases | 16.5 | 2.24 | −9.7 |
| Cirrhosis and other chronic liver diseases due to hepatitis B | 4.8 | 0.65 | −14.3 |
| Cirrhosis and other chronic liver diseases due to hepatitis C | 4.2 | 0.57 | −8.4 |
| Cirrhosis and other chronic liver diseases due to alcohol use | 4.1 | 0.56 | −8.8 |
| Cirrhosis due to NASH | 1.5 | 0.2 | −1.4 |
| Cirrhosis and other chronic liver diseases due to other causes | 1.9 | 0.26 | −8.6 |
| Upper digestive system diseases | 3.8 | 0.52 | −21.6 |
| Peptic ulcer disease | 3.1 | 0.42 | −23.5 |
| Gastritis and duodenitis | 0.7 | 0.09 | −11.7 |
| Appendicitis | 0.6 | 0.08 | −17.0 |
| Paralytic ileus and intestinal obstruction | 3.2 | 0.43 | −5.8 |
| Inguinal, femoral, and abdominal hernia | 0.6 | 0.08 | −8.9 |
| Inflammatory bowel disease | 0.5 | 0.07 | −10.5 |
| Vascular intestinal disorders | 1.3 | 0.18 | −10.2 |
| Gallbladder and biliary diseases | 1.5 | 0.2 | −5.0 |
| Pancreatitis | 1.3 | 0.18 | −5.7 |
| Other digestive diseases | 1.2 | 0.16 | −7.1 |
| Neurological disorders | 43.1 | 5.84 | 0.1 |
| Alzheimer's disease and other dementias | 35.4 | 4.8 | 0.6 |
| Parkinson's disease | 4.6 | 0.62 | 0.8 |
| Epilepsy | 1.7 | 0.23 | −10.7 |
| Multiple sclerosis | 0.3 | 0.04 | −3.9 |
| Motor neuron disease | 0.4 | 0.05 | 1.2 |
| Other neurological disorders | 0.7 | 0.09 | 2.0 |
| Mental disorders | 0 | 0 | 7.5 |
| Eating disorders | 0 | 0 | 7.5 |
| Anorexia nervosa | 0 | 0 | 5.5 |
| Bulimia nervosa | 0 | 0 | 13.5 |
| Substance use disorders | 4.3 | 0.58 | 2.0 |
| Alcohol use disorders | 2.3 | 0.31 | −16.5 |
| Drug use disorders | 2.1 | 0.28 | 34.1 |
| Opioid use disorders | 1.4 | 0.19 | 49.4 |
| Cocaine use disorders | 0.1 | 0.01 | 19.6 |
| Amphetamine use disorders | 0.1 | 0.01 | 8.7 |
| Other drug use disorders | 0.6 | 0.08 | 11.3 |
| Diabetes and kidney diseases | 33.6 | 4.55 | 1.3 |
| Diabetes mellitus | 17.5 | 2.37 | 1.2 |
| Diabetes mellitus type 1 | 4.3 | 0.58 | −11.0 |
| Diabetes mellitus type 2 | 13.2 | 1.79 | 5.9 |
| Chronic kidney disease | 15.9 | 2.16 | 1.5 |
| Chronic kidney disease due to diabetes mellitus type 1 | 0.9 | 0.12 | −1.2 |
| Chronic kidney disease due to diabetes mellitus type 2 | 4.5 | 0.61 | 4.2 |
| Chronic kidney disease due to hypertension | 4.6 | 0.62 | 3.2 |
| Chronic kidney disease due to glomerulonephritis | 2.4 | 0.33 | −1.3 |
| Chronic kidney disease due to other and unspecified causes | 3.4 | 0.46 | −1.4 |
| Acute glomerulonephritis | 0.1 | 0.01 | −9.5 |
| Skin and subcutaneous diseases | 1.3 | 0.18 | 8.1 |
| Bacterial skin diseases | 1 | 0.14 | 12.7 |
| (Cellulitis) | 0.2 | 0.03 | 19.6 |
| (Pyoderma) | 0.8 | 0.11 | 10.5 |
| Decubitus ulcer | 0.3 | 0.04 | −5.1 |
| Other skin and subcutaneous diseases | 0.1 | 0.01 | 3.3 |
| Musculoskeletal disorders | 1.6 | 0.22 | −0.1 |
| Rheumatoid arthritis | 0.6 | 0.08 | −5.9 |
| Other musculoskeletal disorders | 1 | 0.14 | 3.9 |
| Other non-communicable diseases | 16.3 | 2.21 | −11.2 |
| Congenital anomalies | 8.7 | 1.18 | −18.2 |
| Neural tube defects | 0.9 | 0.12 | −16.5 |
| Congenital heart anomalies | 3.9 | 0.53 | −21.8 |
| Orofacial clefts | 0.1 | 0.01 | −41.9 |
| Down syndrome | 0.4 | 0.05 | −5.2 |
| Other chromosomal abnormalities | 0.3 | 0.04 | 0.3 |
| Congenital musculoskeletal and limb anomalies | 0.2 | 0.03 | −12.8 |
| Urogenital congenital anomalies | 0.2 | 0.03 | −8.5 |
| Digestive congenital anomalies | 0.8 | 0.11 | −19.3 |
| Other congenital anomalies | 2.1 | 0.28 | −15.9 |
| Urinary diseases and male infertility | 3.6 | 0.49 | 5.7 |
| Urinary tract infections | 2.7 | 0.37 | 10.9 |
| Urolithiasis (Kidney stone disease) | 0.2 | 0.03 | −1.2 |
| Other urinary diseases | 0.7 | 0.09 | −9.9 |
| Gynecological diseases | 0.1 | 0.01 | −2.6 |
| Uterine fibroids | 0 | 0 | 8.1 |
| Polycystic ovarian syndrome | 0 | 0 | 1.0 |
| Endometriosis | 0 | 0 | −3.2 |
| Genital prolapse | 0 | 0 | −24.1 |
| Other gynecological diseases | 0.1 | 0.01 | −3.6 |
| Hemoglobinopathies and hemolytic anaemias | 1.4 | 0.19 | −11.3 |
| Thalassemias | 0.1 | 0.01 | −27.9 |
| Sickle cell disorders | 0.5 | 0.07 | −3.1 |
| G6PD deficiency | 0.2 | 0.03 | −7.1 |
| Other hemoglobinopathies and hemolytic anaemias | 0.6 | 0.08 | −16.1 |
| Endocrine, metabolic, blood, and immune disorders | 1.9 | 0.26 | 0.8 |
| Sudden infant death syndrome | 0.6 | 0.08 | −20.2 |
| III. Injuries | 57.9 | 7.85 | −13.7 |
| Transport injuries | 17 | 2.3 | −17.0 |
| Road injuries | 15.8 | 2.14 | −17.1 |
| Pedestrian road injuries | 6.2 | 0.84 | −21.4 |
| Cyclist road injuries | 0.9 | 0.12 | −8.8 |
| Motorcyclist road injuries | 2.9 | 0.39 | −12.4 |
| Motor vehicle road injuries | 5.8 | 0.79 | −15.6 |
| Other road injuries | 0.1 | 0.01 | −19.4 |
| Other transport injuries | 1.2 | 0.16 | −15.5 |
| Unintentional injuries | 23.8 | 3.23 | −15.3 |
| Falls | 9.2 | 1.25 | −2.8 |
| Drowning | 4 | 0.54 | −27.3 |
| Fire, heat, and hot substances | 1.6 | 0.22 | −22.9 |
| Poisonings | 0.9 | 0.12 | −20.8 |
| (Poisoning by carbon monoxide) | 0.5 | 0.07 | −26.6 |
| (Poisoning by other means) | 0.5 | 0.07 | −14.4 |
| Exposure to mechanical forces | 1.8 | 0.24 | −20.3 |
| (Unintentional firearm injuries) | 0.3 | 0.04 | −16.4 |
| (Other exposure to mechanical forces) | 1.5 | 0.2 | −21.0 |
| Adverse effects of medical treatment | 1.6 | 0.22 | −6.2 |
| Animal contact | 1.1 | 0.15 | −16.0 |
| (Venomous animal contact) | 0.9 | 0.12 | −16.0 |
| (Non-venomous animal contact) | 0.1 | 0.01 | −16.1 |
| Foreign body | 1.7 | 0.23 | −14.1 |
| (Pulmonary aspiration and foreign body in airway) | 1.6 | 0.22 | −13.9 |
| (Foreign body in other body part) | 0.1 | 0.01 | −15.8 |
| Environmental heat and cold exposure | 0.7 | 0.09 | −29.4 |
| Exposure to forces of nature | 0.1 | 0.01 | −45.8 |
| Other unintentional injuries | 1.2 | 0.16 | −25.8 |
| Self-harm and interpersonal violence | 17.1 | 2.32 | −7.6 |
| Self-harm | 10 | 1.36 | −14.8 |
| Self-harm by firearm | 0.8 | 0.11 | −10.3 |
| Self-harm by other specified means | 9.2 | 1.25 | −15.2 |
| Interpersonal violence | 5.2 | 0.7 | −11.1 |
| Assault by firearm | 2.2 | 0.3 | −3.6 |
| Assault by sharp object | 1.2 | 0.16 | −22.3 |
| Assault by other means | 1.8 | 0.24 | −11.5 |
| Conflict and terrorism | 1.7 | 0.23 | 98.4 |
| Executions and police conflict | 0.2 | 0.03 | 172.4 |
Loading community rankings...